Biotest AG (XTER:BIO)
€ 41 0 (0%) Market Cap: 1.34 Bil Enterprise Value: 1.83 Bil PE Ratio: 7.95 PB Ratio: 3.07 GF Score: 68/100

Q4 2021 Biotest AG Earnings Call Transcript

Mar 24, 2022 / NTS GMT
Release Date Price: €42.1 (-1.64%)
Operator

Good day, and welcome to the Biotest AG Full Year Results 2021 Conference Call. Today's conference is being recorded. At this time, I would like to turn the conference over to Ms. Monika Buttkereit. Please go ahead, ma'am.

Monika Buttkereit
Biotest Aktiengesellschaft - Head of IR

Thank you very much, Jess. Good afternoon, ladies and gentlemen, and welcome to our today's full year 2021 results conference call. It's a pleasure to have you here on the call for Michael Ramroth, CEO and CFO of Biotest AG and myself. We have prepared a presentation for you, which can be found on the Investor Relations website of our company. And here, you can follow the presentation slides while we go through our presentation.

I will now hand over to Michael.

Michael Ramroth
Biotest Aktiengesellschaft - Chairman of the Management Board, CEO & CFO

Yes. Thank you very much. And also a warm welcome from my side on this sunny Thursday afternoon. It's the first time that we publish and issue our results so early in March. And we

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot